Bioventus Inc (BVS)
13.58
+0.01
(+0.07%)
USD |
NASDAQ |
Nov 01, 16:00
13.59
+0.01
(+0.07%)
After-Hours: 20:00
Bioventus Debt to Equity Ratio: 2.539 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.539 |
| March 31, 2024 | 2.284 |
| December 31, 2023 | 2.275 |
| September 30, 2023 | 2.223 |
| June 30, 2023 | 2.106 |
| March 31, 2023 | 2.364 |
| December 31, 2022 | 1.285 |
| September 30, 2022 | 1.236 |
| June 30, 2022 | 0.8348 |
| March 31, 2022 | 0.8189 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.7794 |
| September 30, 2021 | 1.164 |
| June 30, 2021 | 1.279 |
| March 31, 2021 | 1.297 |
| December 31, 2020 | 1.307 |
| September 30, 2020 | 1.350 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 1.384 |
| March 31, 2016 | 0.985 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7794
Minimum
Dec 2021
2.539
Maximum
Jun 2024
1.560
Average
1.307
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5187 |
| Insulet Corp | 1.40 |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 0.7481 |
| Catheter Precision Inc | 0.0454 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 792.17M |
| Total Liabilities (Quarterly) | 603.11M |
| Shareholders Equity (Quarterly) | 150.94M |
| Current Ratio | 1.334 |
| Net Debt Paydown Yield | 3.33% |